According to our recent payer coverage analysis for chronic heart failure treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.
To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.
Payer Coverage: A look at market access over the past two quarters shows that the percentage of restricted health exchange lives increased.
Source: MMIT data as of Q4 2016
Trends: A major trend related to chronic heart failure treatment is the spotlight on prescribing habits. New research shows the challenges for congestive heart failure prescribers with an average heart failure patient taking an average of 7 medications that could result in dangerous adverse events.
To read the full Reality Check on Heart Failure with key findings on clinical characteristics, acne drug market access and payer coverage, please click on the button below: